메뉴 건너뛰기




Volumn 93, Issue 3-4, 2009, Pages 541-548

Innovation and the welfare effects of public drug insurance

Author keywords

Health insurance; Innovation; Prescription drugs

Indexed keywords


EID: 61549107708     PISSN: 00472727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpubeco.2008.11.003     Document Type: Article
Times cited : (61)

References (21)
  • 1
    • 0001413441 scopus 로고
    • The marginal cost of public funds
    • Browning E.K. The marginal cost of public funds. Journal of Political Economy 84 2 (1976) 283-298
    • (1976) Journal of Political Economy , vol.84 , Issue.2 , pp. 283-298
    • Browning, E.K.1
  • 2
    • 0002257846 scopus 로고
    • Patent expiration, entry, and competition in the US pharmaceutical industry
    • Caves R.E., Whinston M.D., et al. Patent expiration, entry, and competition in the US pharmaceutical industry. Brookings Papers on Economic Activity (1991) 1-48
    • (1991) Brookings Papers on Economic Activity , pp. 1-48
    • Caves, R.E.1    Whinston, M.D.2
  • 3
    • 0006144883 scopus 로고    scopus 로고
    • Does public insurance crowd out private insurance?
    • Cutler D.M., and Gruber J. Does public insurance crowd out private insurance?. Quarterly Journal of Economics 112 2 (1996) 391-430
    • (1996) Quarterly Journal of Economics , vol.112 , Issue.2 , pp. 391-430
    • Cutler, D.M.1    Gruber, J.2
  • 5
    • 33644870984 scopus 로고    scopus 로고
    • The distortionary effects of government procurement: evidence from medicaid prescription drug purchasing.
    • Duggan M., and Scott Morton F.M. The distortionary effects of government procurement: evidence from medicaid prescription drug purchasing. Quarterly Journal of Economics 121 1 (2006) 1-30
    • (2006) Quarterly Journal of Economics , vol.121 , Issue.1 , pp. 1-30
    • Duggan, M.1    Scott Morton, F.M.2
  • 6
    • 0041125784 scopus 로고    scopus 로고
    • Tax avoidance and the deadweight loss of the income tax.
    • Feldstein M. Tax avoidance and the deadweight loss of the income tax. Review of Economics and Statistics 81 4 (1999) 674-680
    • (1999) Review of Economics and Statistics , vol.81 , Issue.4 , pp. 674-680
    • Feldstein, M.1
  • 7
    • 38849203212 scopus 로고    scopus 로고
    • Should drug prices be negotiated under Part D of medicare? And if so, how?
    • Frank R.G., and Newhouse J.P. Should drug prices be negotiated under Part D of medicare? And if so, how?. Health Affairs 27 1 (2008) 33-43
    • (2008) Health Affairs , vol.27 , Issue.1 , pp. 33-43
    • Frank, R.G.1    Newhouse, J.P.2
  • 9
    • 33749343314 scopus 로고    scopus 로고
    • Benefit design and specialty drug use.
    • (Millwood)
    • Goldman D.P., Joyce G.F., et al. Benefit design and specialty drug use. Health Affairs 25 5 (2006) 1319-1331 (Millwood)
    • (2006) Health Affairs , vol.25 , Issue.5 , pp. 1319-1331
    • Goldman, D.P.1    Joyce, G.F.2
  • 11
    • 0009009362 scopus 로고    scopus 로고
    • Patent buyouts: a mechanism for encouraging innovation
    • Kremer M. Patent buyouts: a mechanism for encouraging innovation. Quarterly Journal of Economics 113 4 (1998) 1137-1167
    • (1998) Quarterly Journal of Economics , vol.113 , Issue.4 , pp. 1137-1167
    • Kremer, M.1
  • 15
    • 36849059199 scopus 로고    scopus 로고
    • The impact of Medicare Part D on prescription drug use by the elderly
    • Lichtenberg F.R., and Sun S.X. The impact of Medicare Part D on prescription drug use by the elderly. Health Affairs 26 6 (2007) 1735-1744
    • (2007) Health Affairs , vol.26 , Issue.6 , pp. 1735-1744
    • Lichtenberg, F.R.1    Sun, S.X.2
  • 19
    • 0031153344 scopus 로고    scopus 로고
    • The strategic response by pharmaceutical firms to the medicaid most-favored-customer rules
    • Scott Morton F. The strategic response by pharmaceutical firms to the medicaid most-favored-customer rules. Rand Journal of Economics 28 2 (1997) 269-290
    • (1997) Rand Journal of Economics , vol.28 , Issue.2 , pp. 269-290
    • Scott Morton, F.1
  • 21
    • 61549134614 scopus 로고    scopus 로고
    • The effect of pharmaceutical regulation on revenues
    • Sood N., de Vries H., et al. The effect of pharmaceutical regulation on revenues. Health Affairs 28 (1) (2009)
    • (2009) Health Affairs 28 (1)
    • Sood, N.1    de Vries, H.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.